Migraine Focus Axon Optics specializes in light-blocking lenses designed to reduce migraine triggers, indicating a strong niche in a clinically validated solution that can be pitched to headache clinics, optometrists, and neurology practices seeking non-pharmacologic therapies.

Strategic Merger Recent merger with Avulux expands product capabilities and market reach within migraine optics, presenting cross-sell opportunities to existing Avulux customers and synergistic product bundles for neurology-focused retailers and clinics.

Early Stage Revenue Current revenue under one million with a lean team suggests high growth potential but limited internal sales capacity, making partnerships, distributors, and key account roles critical to scale quickly.

Digital & E‑commerce Tech stack includes marketing automation and e‑commerce tools (Mailchimp, Klaviyo, PayPal, Google Pay), enabling targeted campaigns to optometry practices and consumer purchasers; leverage for B2B2C and direct-to-consumer outreach.

Clinical Validation Presence of HIT-6 survey and clinically proven lens implies credibility with healthcare providers; opportunities exist to partner with headache clinics, research networks, and patient advocacy groups to drive referrals and trials.